Wei Li

机构：Union Hospital, Jilin University, Renji Hospital, Soochow University, Shanghai Changzheng Hospital, First Hospital of Jilin University, Shanghai Pulmonary Hospital, First Affiliated Hospital of Soochow University, Union Hospital · ORCID：0009-0008-0018-036X

发表论文 32 篇 · 总被引 360 次 · h-index 10

代表论文

• Mechanisms of drugs-resistance in small cell lung cancer: DNA-related, RNA-related, apoptosis-related, drug accumulation and metabolism procedure (2020 · Translational Lung Cancer Research · 被引 65)
• <p>Expression of PD-1 and PD-L1 on Tumor-Infiltrating Lymphocytes Predicts Prognosis in Patients with Small-Cell Lung Cancer</p> (2020 · OncoTargets and Therapy · 被引 44)
• Characteristics of Notch signaling pathway and its correlation with immune microenvironment in SCLC (2022 · Lung Cancer · 被引 25)
• Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I–III small cell lung cancer (2021 · Journal for ImmunoTherapy of Cancer · 被引 25)
• Personalized three-year survival prediction and prognosis forecast by interpretable machine learning for pancreatic cancer patients: a population-based study and an external validation (2024 · Frontiers in Oncology · 被引 11)
• Efficacy and Safety of Anlotinib Monotherapy as Third-Line Therapy for Elderly Patients with Non-Small Cell Lung Cancer: A Real-World Exploratory Study (2021 · International Journal of General Medicine · 被引 11)